Testing Pediatric Rheumatology Diagnostic Decision Support in Clinical Use
1 other identifier
interventional
15
1 country
1
Brief Summary
This study is designed to test the helpfulness of a diagnostic tool, SimulConsult, when clinicians are diagnosing pediatric rheumatic diseases. Trainees and nurse practitioners will use the software or not use it, and their differential diagnoses will be compared to those of attending physicians in the same clinical encounter, and then to definitive diagnoses weeks later after testing, if one is reached.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2021
CompletedStudy Start
First participant enrolled
April 20, 2021
CompletedFirst Posted
Study publicly available on registry
April 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedOctober 4, 2022
September 1, 2022
2.7 years
March 17, 2021
September 30, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Performance against Gold Standard: Presence of Gold standard #1 diagnosis in trainee list
The study will compare the trainee's differential diagnosis and workup plan to those of the attending physician seeing the same patient. The Attending is considered at this stage as the "gold standard" and we aim to answer the question "how well does a trainee with a DDSS (and traditional resources) approximate an experienced, specialist Attending vs. a trainee with access only to more traditional resources?".
1 day
Secondary Outcomes (1)
Performance against definitive diagnosis: Presence of definitive diagnosis in trainee list
6 weeks
Study Arms (2)
Intervention (Use of diagnostic decision support software)
EXPERIMENTALTrainee or nurse practitioner sees patient and uses diagnostic decision support software in developing their differential diagnosis and plan
Control (Current process)
NO INTERVENTIONTrainee or nurse practitioner sees patient but doesn't use diagnostic decision support software in developing their differential diagnosis and plan
Interventions
Comparing use of decision support group (intervention group) to use only of common literature (control group) among pediatric trainees diagnosing patients with possible rheumatologic disorder
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- PhenoSolve, LLClead
- Boston Children's Hospitalcollaborator
Study Sites (1)
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
Related Publications (4)
Segal MM. Mobile medical computing driven by the complexity of neurologic diagnosis. J Child Neurol. 2006 Jul;21(7):595-9. doi: 10.1177/08830738060210071601.
PMID: 16970851BACKGROUNDSegal MM, Athreya B, Son MB, Tirosh I, Hausmann JS, Ang EY, Zurakowski D, Feldman LK, Sundel RP. Evidence-based decision support for pediatric rheumatology reduces diagnostic errors. Pediatr Rheumatol Online J. 2016 Dec 13;14(1):67. doi: 10.1186/s12969-016-0127-z.
PMID: 27964737BACKGROUNDStaffa SJ, Zurakowski D. Strategies in adjusting for multiple comparisons: A primer for pediatric surgeons. J Pediatr Surg. 2020 Sep;55(9):1699-1705. doi: 10.1016/j.jpedsurg.2020.01.003. Epub 2020 Jan 23.
PMID: 32029234BACKGROUNDSegal MM, Williams MS, Gropman AL, Torres AR, Forsyth R, Connolly AM, El-Hattab AW, Perlman SJ, Samanta D, Parikh S, Pavlakis SG, Feldman LK, Betensky RA, Gospe SM Jr. Evidence-based decision support for neurological diagnosis reduces errors and unnecessary workup. J Child Neurol. 2014 Apr;29(4):487-92. doi: 10.1177/0883073813483365. Epub 2013 Apr 10.
PMID: 23576414BACKGROUND
Study Officials
- STUDY CHAIR
Michael M Segal, MD PhD
PhenoSolve, LLC
- PRINCIPAL INVESTIGATOR
Robert P Sundel, MD
Boston Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- No masking is possible for subjects, since they will know whether they are or are not using the software.
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2021
First Posted
April 23, 2021
Study Start
April 20, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
October 4, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- 2021-2022
The results will be shared.